表紙
市場調查報告書

次世代定序 (NGS)的全球市場 ∼2025年:NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE

Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 235782
出版日期 內容資訊 英文 228 Pages
訂單完成後即時交付
價格
Back to Top
次世代定序 (NGS)的全球市場 ∼2025年:NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025
出版日期: 2019年12月02日內容資訊: 英文 228 Pages
簡介

全球次世代定序 (NGS) 市場在2019年估算為78億美元,預計2025年達244億美元,並以20.9%的年複合成長率 (CAGR) 成長。市場成長的主要原因,是技術改良和降低成本,相關法規和醫療費償付方案的重新評估等。各用途中的診斷檢驗,各地區中的北美市場佔最大的佔有率。

本報告提供全球NGS (次世代定序) 市場相關分析,市場基本結構和最新形勢,主要市場促進、阻礙因素,市場趨勢預測 (過去2年、今後7年份),各產品/服務、各技術、各用途、各終端用戶、各地區的詳細趨勢,市場競爭的狀態,主要企業簡介等調查。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • NGS平台的進步 (iSeq,Ion GeneStudio S5)
      • 成本低
      • NGS為基礎的診斷檢驗的法規改善與醫療費償付方案
    • 阻礙因素
      • 開發中國家的終端用戶的預算規定
    • 市場機會
      • 對大規模定序的公民營雙方的支援
      • 在精密醫療、分子診斷上NGS的有效利用
      • 使用了巨量資料的NGS資料分析
    • 課題
      • 來自NGS平台的複雜的資料的解釋
      • 倫理的問題
    • 產業趨勢
      • 便攜的定序技術的開發
      • NGS的技術開發的合作、聯盟

第6章 次世代定序 (NGS) 市場:各產品、服務

  • 簡介
  • 預先排序產品/服務,樣品製作
    • 程序庫調整、標靶序列捕獲
    • 品管
  • NGS用消耗品
  • NGS平台
    • ILLUMINA
      • HiSeq systems
      • HiSeq X Ten & HiSeq X Five systems
      • MiSeq systems
      • NextSeq systems
      • MiniSeq systems
      • NovaSeq systems
      • iSeq 100 systems
    • THERMO FISHER SCIENTIFIC
      • Ion PGM systems
      • Ion proton
      • Ion GeneStudio S5
    • OXFORD NANOPORE TECHNOLOGIES
      • PacBio RS II
      • Sequel systems
    • PACIFIC BIOSCIENCES
    • 其他
  • NGS平台服務
  • 定序服務
    • EXOME/目標重定序,自訂面板
    • RNA定序 (RNA-SEQ)
    • 全基因定序,De Novo定序
    • 其他
  • 生物資訊學
    • NGS資料分析軟體/工作台
    • NGS資料分析服務
    • NGS儲存/管理/雲端運算、解決方案

第7章 次世代定序 (NGS) 市場:各技術

  • 簡介
  • 合成法定序 (SBS)
  • 離子半導體定序 (ION)
  • SMRT (一分子即時定序)
  • 奈米細孔定序
  • 其他定序技術

第8章 次世代定序 (NGS) 市場:各用途

  • 簡介
  • 診斷
    • 癌症診斷
    • 感染疾病診斷
    • 生殖健康
    • 其他
  • 藥物研發
  • 農業、動物研究
  • 其他

第9章 次世代定序 (NGS) 市場:各終端用戶

  • 簡介
  • 教育機關、研究中心
  • 製藥、生物科技企業
  • 醫院、診療所
  • 其他

第10章 次世代定序 (NGS) 市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (德國,法國,英國,西班牙,義大利,荷蘭等)
  • 亞太地區 (中國,日本,澳洲,印度等)
  • 南美 (巴西,墨西哥等)
  • 中東、非洲

第11章 競爭環境

  • 簡介
  • 企業策略方向性:製圖 (市場全體)
    • 企業先驅
    • 創新的企業
    • 活動的企業
    • 新企業
  • 競爭方案
  • 次世代定序 (NGS)的市場排行榜:大3公司的情況

第12章 企業簡介 (產業概要,主要產品與服務,近幾年趨勢,MnM的見解)

  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • BGI GROUP
  • PERKINELMER
  • AGILENT TECHNOLOGIES, INC.
  • QIAGEN N.V.
  • F. HOFFMANN-LA ROCHE AG
  • GENEWIZ (BROOKS AUTOMATION的部門)
  • EUROFINS SCIENTIFIC
  • PSOMAGEN, INC. (舊稱:MACROGEN)
  • OXFORD NANOPORE TECHNOLOGIES
  • 10X GENOMICS
  • TaKaRa BIO
  • ZYMO RESEARCH
  • NUGEN TECHNOLOGIES (TECAN TRADING AG的部門)
  • 其他企業
    • HAMILTON COMPANY
    • BECKMAN COULTER (DANAHER的子公司)
    • BECTON, DICKINSON AND COMPANY
    • GENOTYPIC TECHNOLOGY
    • LUCIGEN CORPORATION

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2697

"The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period."

The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. The NGS market is segmented based on application, technology, product & service, end user, and region.

"The SBS segment accounted for the largest share of the NGS market in 2018."

On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina's systems, as it is the major provider of SBS-based NGS platforms (including the HiSeq MiSeq series and NextSeq).

"The diagnostics application segment accounted for the largest share of the NGS market in 2018."

Based on applications, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

"North America accounted for the largest share of the NGS market in 2018."

North America accounted for the largest share of the NGS market in 2018, followed by Europe. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

Some of the prominent players in the NGS market include: Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann- La Roche Ltd (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands).

Research Coverage:

This report studies the NGS market based on product & service, technology, application, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four major regions and their respective major countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the NGS market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 APPLICATION-BASED MARKET ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW
  • 4.2 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2025 (USD MILLION)
  • 4.3 NEXT-GENERATION SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2019 VS. 2025
  • 4.4 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2019 VS. 2025 (USD MILLION)
  • 4.5 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2019 VS. 2025 (USD MILLION)
  • 4.6 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHICAL SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advancements in NGS platforms
        • 5.2.1.1.1 iSeq
        • 5.2.1.1.2 Ion GeneStudio S5
      • 5.2.1.2 Declining costs
      • 5.2.1.3 Improving regulatory and reimbursement scenario for NGS-based diagnostic tests
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 End-user budget constraints in developing nations
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Government & private support for large-scale sequencing
      • 5.2.3.2 Application of NGS in precision medicine and molecular diagnostics
      • 5.2.3.3 NGS data analysis using big data
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Interpretation of complex data from NGS platforms
      • 5.2.4.2 Ethical issues
    • 5.2.5 INDUSTRY TRENDS
      • 5.2.5.1 Development of portable sequencing technologies
      • 5.2.5.2 Partnerships & collaborations for technological advancements in NGS

6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 PRESEQUENCING PRODUCTS & SERVICES/SAMPLE PREPARATION
    • 6.2.1 INCREASING AUTOMATION IN SAMPLE PREPARATION TO DRIVE MARKET GROWTH
      • 6.2.1.1 Library preparation & target enrichment
      • 6.2.1.2 Quality control
  • 6.3 NGS CONSUMABLES
    • 6.3.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL THE DEMAND FOR NGS CONSUMABLES
  • 6.4 NGS PLATFORMS
    • 6.4.1 SIGNIFICANT TRANSFORMATION EXPERIENCED IN THE MARKET DUE TO ENTRY OF NEW NGS PLATFORM PROVIDERS
    • 6.4.2 ILLUMINA
      • 6.4.2.1 HiSeq systems
      • 6.4.2.2 HiSeq X Ten & HiSeq X Five systems
      • 6.4.2.3 MiSeq systems
      • 6.4.2.4 NextSeq systems
      • 6.4.2.5 MiniSeq systems
      • 6.4.2.6 NovaSeq systems
      • 6.4.2.7 iSeq 100 systems
    • 6.4.3 THERMO FISHER SCIENTIFIC
      • 6.4.3.1 Ion PGM systems
      • 6.4.3.2 Ion proton
      • 6.4.3.3 Ion GeneStudio S5
    • 6.4.4 OXFORD NANOPORE TECHNOLOGIES
    • 6.4.5 PACIFIC BIOSCIENCES
      • 6.4.5.1 PacBio RS II
      • 6.4.5.2 Sequel systems
    • 6.4.6 OTHER NGS PLATFORMS
  • 6.5 SERVICES FOR NGS PLATFORMS
    • 6.5.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET GROWTH
  • 6.6 SEQUENCING SERVICES
    • 6.6.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
      • 6.6.1.1 Development of technologically advanced NGS products & services to propel market growth
    • 6.6.2 RNA-SEQ
      • 6.6.2.1 Launch of advanced RNA products & services to drive market growth
    • 6.6.3 WHOLE-GENOME SEQUENCING & DE NOVO SEQUENCING
      • 6.6.3.1 Reducing whole-genome sequencing costs to propel the growth of this segment
    • 6.6.4 OTHER SEQUENCING SERVICES
  • 6.7 BIOINFORMATICS
    • 6.7.1 NGS DATA ANALYSIS SOFTWARE & WORKBENCHES
      • 6.7.1.1 Development of advanced bioinformatics solutions to drive growth in this segment
    • 6.7.2 NGS DATA ANALYSIS SERVICES
      • 6.7.2.1 Availability of data analysis services is the major factor supporting the growth of this market.
    • 6.7.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
      • 6.7.3.1 Launch of cloud-based solutions to drive the market

7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 SEQUENCING BY SYNTHESIS
    • 7.2.1 SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
  • 7.3 ION SEMICONDUCTOR SEQUENCING
    • 7.3.1 ION SEMICONDUCTOR SEQUENCING PLATFORMS POSSESS HIGH-THROUGHPUT CAPABILITIES
  • 7.4 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.4.1 SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
  • 7.5 NANOPORE SEQUENCING
    • 7.5.1 NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
  • 7.6 OTHER SEQUENCING TECHNOLOGIES

8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DIAGNOSTICS
    • 8.2.1 CANCER DIAGNOSTICS
      • 8.2.1.1 Growing number of new cancer cases to propel market growth
    • 8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
      • 8.2.2.1 Lack of awareness about NGS-based diagnosis for infectious diseases to hamper market growth
    • 8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
      • 8.2.3.1 Increasing awareness about the benefits of NIPT to propel market growth
    • 8.2.4 OTHER DIAGNOSTIC APPLICATIONS
  • 8.3 DRUG DISCOVERY
    • 8.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS FOR DRUG DISCOVERY TO SUPPORT MARKET GROWTH
  • 8.4 AGRICULTURAL & ANIMAL RESEARCH
    • 8.4.1 GROWING FUNDING & SUPPORT FOR ANIMAL & PLANT GENOMICS RESEARCH TO DRIVE MARKET GROWTH
  • 8.5 OTHER APPLICATIONS

9 NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS
    • 9.2.1 DEVELOPMENT OF COST-EFFECTIVE NGS PRODUCTS & SERVICES FOR RESEARCHERS TO PROPEL MARKET GROWTH
  • 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.3.1 GROWING AGREEMENTS & COLLABORATIONS BETWEEN NEXT-GENERATION SEQUENCING MARKET PLAYERS AND PHARMA BIOTECH FIRMS TO FUEL MARKET GROWTH
  • 9.4 HOSPITALS & CLINICS
    • 9.4.1 DEVELOPMENT OF ADVANCED NGS-BASED DIAGNOSTIC SOLUTIONS TO ENHANCE THE ADOPTION OF NGS IN HOSPITALS & CLINICS
  • 9.5 OTHER END USERS

10 NEXT-GENERATION SEQUENCING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Growing R&D activities in the US to drive market growth
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of NGS
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates the European next-generation sequencing market
    • 10.3.2 FRANCE
      • 10.3.2.1 Government initiatives to support genomics research-a major factor driving market growth in France
    • 10.3.3 UK
      • 10.3.3.1 Favorable funding scenario for genomics research in the country to support the adoption of NGS
    • 10.3.4 SPAIN
      • 10.3.4.1 Increasing number of conferences focusing on NGS to support market growth in Spain
    • 10.3.5 ITALY
      • 10.3.5.1 Favorable funding scenario to drive the next-generation sequencing market in Italy
    • 10.3.6 NETHERLANDS
      • 10.3.6.1 Increasing focus of market players on developing NGS technologies to support market growth
    • 10.3.7 ROE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 China to register the highest growth in the APAC next-generation sequencing market
    • 10.4.2 JAPAN
      • 10.4.2.1 High incidence of genetic disorders in the country has resulted in the increased adoption of NGS
    • 10.4.3 AUSTRALIA
      • 10.4.3.1 Increasing public and private initiatives to support the adoption of NGS technologies in Australia
    • 10.4.4 INDIA
      • 10.4.4.1 Growing prevalence of target diseases in India to support market growth
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 High prevalence of HIV in Brazil to drive the demand for NGS
    • 10.5.2 MEXICO
      • 10.5.2.1 Economic growth in Mexico to support the growth of the next-generation sequencing market
    • 10.5.3 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 LACK OF INFRASTRUCTURE FOR GENOMICS RESEARCH TO HAMPER THE GROWTH OF THE NEXT-GENERATION SEQUENCING MARKET IN THE MEA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
    • 11.2.1 TERMINOLOGY/NOMENCLATURE
      • 11.2.1.1 Visionary leaders
      • 11.2.1.2 Innovators
      • 11.2.1.3 Dynamic differentiators
      • 11.2.1.4 Emerging companies
  • 11.3 COMPETITIVE SCENARIO (2016-2019)
  • 11.4 NEXT-GENERATION SEQUENCING MARKET RANKING: TOP THREE MARKET PLAYERS (2018)

12 COMPANY PROFILES

(Business overview, Products and Services offered, Recent developments, MNM view)*

  • 12.1 ILLUMINA, INC.
  • 12.2 THERMO FISHER SCIENTIFIC, INC.
  • 12.3 BGI GROUP
  • 12.4 PERKINELMER
  • 12.5 AGILENT TECHNOLOGIES, INC.
  • 12.6 QIAGEN N.V.
  • 12.7 F. HOFFMANN-LA ROCHE AG
  • 12.8 GENEWIZ (A PART OF BROOKS AUTOMATION)
  • 12.9 EUROFINS SCIENTIFIC
  • 12.10 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN)
  • 12.11 OXFORD NANOPORE TECHNOLOGIES
  • 12.12 10X GENOMICS
  • 12.13 TAKARA BIO
  • 12.14 ZYMO RESEARCH
  • 12.15 NUGEN TECHNOLOGIES (A PART OF TECAN TRADING AG)
  • 12.16 OTHER COMPANIES
    • 12.16.1 HAMILTON COMPANY
    • 12.16.2 BECKMAN COULTER (A SUBSIDIARY OF DANAHER)
    • 12.16.3 BECTON, DICKINSON AND COMPANY
    • 12.16.4 GENOTYPIC TECHNOLOGY
    • 12.16.5 LUCIGEN CORPORATION

Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL SEQUENCING INITIATIVES
  • TABLE 2: PARTNERSHIPS & COLLABORATIONS, 2017-2019
  • TABLE 3: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 4: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 5: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 6: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 7: QUALITY CONTROL MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 8: NGS CONSUMABLES MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 9: NGS PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 10: NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 11: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 12: ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 13: HISEQ SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 14: HISEQ X TEN & HISEQ X FIVE MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 15: MISEQ SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 16: NEXTSEQ SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 17: MINISEQ SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 18: NOVASEQ SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 19: ISEQ 100 SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 20: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 21: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 22: ION PGM PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 23: ION PROTON SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 24: ION GENESTUDIO S5 PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 25: OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 26: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 27: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 28: PACBIO RS II SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 29: SEQUEL SYSTEMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 30: OTHER NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 31: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 32: NGS SEQUENCING SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 33: NGS SEQUENCING SERVICES MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 34: NGS BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 35: NGS BIOINFORMATICS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 36: NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
  • TABLE 37: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 38: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 39: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 40: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 41: NANOPORE SEQUENCING MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 42: OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 43: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 44: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 45: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 46: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 47: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 48: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 49: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 50: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 51: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 52: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 53: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 54: NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 55: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 56: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 57: NORTH AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 58: NORTH AMERICA: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 59: NORTH AMERICA: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 60: NORTH AMERICA: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 61: NORTH AMERICA: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 62: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 63: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 64: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 65: US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 66: CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 67: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 68: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 69: EUROPE: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 70: EUROPE: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 71: EUROPE: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 72: EUROPE: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 73: EUROPE: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 74: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 75: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 76: EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 77: GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 78: FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 79: UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 80: SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 81: ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 82: NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 83: ROE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 84: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 85: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 86: ASIA PACIFIC: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 87: ASIA PACIFIC: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 88: ASIA PACIFIC: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 89: ASIA PACIFIC: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 90: ASIA PACIFIC: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 91: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 92: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 93: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 94: CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 95: JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 96: AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 97: INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 98: ROAPAC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 99: LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 100: LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 101: LATIN AMERICA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 102: LATIN AMERICA: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 103: LATIN AMERICA: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 104: LATIN AMERICA: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 105: LATIN AMERICA: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 106: LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 107: LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 108: LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 109: BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 110: MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 111: ROLA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 112: MEA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 113: MEA: PRESEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 114: MEA: NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 115: MEA: ILLUMINA PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 116: MEA: THERMO FISHER SCIENTIFIC PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 117: MEA: PACIFIC BIOSCIENCES PLATFORMS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 118: MEA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 119: MEA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 120: MEA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 121: NEW PRODUCT LAUNCHES
  • TABLE 122: ACQUISITIONS
  • TABLE 123: PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: NEXT-GENERATION SEQUENCING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: NEXT-GENERATION SEQUENCING MARKET: PRODUCT-BASED ESTIMATION
  • FIGURE 5: NGS PLATFORMS MARKET: PRODUCT-BASED ESTIMATION
  • FIGURE 6: NEXT-GENERATION SEQUENCING MARKET: APPLICATION-BASED ESTIMATION
  • FIGURE 7: NEXT-GENERATION SEQUENCING MARKET: DATA TRIANGULATION
  • FIGURE 8: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 9: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2019 VS. 2025 (USD MILLION)
  • FIGURE 10: NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2019 VS. 2025
  • FIGURE 11: NEXT-GENERATION SEQUENCING MARKET SHARE, BY END USER, 2019 VS. 2025
  • FIGURE 12: NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 13: ADVANCEMENTS AND DECLINING COSTS IN NGS PLATFORMS TO DRIVE MARKET GROWTH
  • FIGURE 14: NGS CONSUMABLES TO DOMINATE THE NEXT-GENERATION SEQUENCING MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: SEQUENCING BY SYNTHESIS TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: DIAGNOSTIC APPLICATIONS TO HOLD THE LARGEST SHARE OF THE NEXT-GENERATION SEQUENCING MARKET IN 2019
  • FIGURE 17: ACADEMIC INSTITUTES & RESEARCH CENTERS TO DOMINATE THE NEXT-GENERATION SEQUENCING MARKET IN 2019
  • FIGURE 18: CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 19: NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
  • FIGURE 21: DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
  • FIGURE 22: FUNDING FOR CANCER RESEARCH IN THE US (2018)
  • FIGURE 23: NUMBER OF PUBMED RESEARCH PUBLICATIONS ON NGS-BASED DRUG DISCOVERY, 2008-2017
  • FIGURE 24: NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 25: EUROPE: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
  • FIGURE 27: NEXT-GENERATION SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 28: NEXT-GENERATION SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 (SMES/START-UPS)
  • FIGURE 29: KEY DEVELOPMENTS IN THE NEXT-GENERATION SEQUENCING MARKET, 2016-2019
  • FIGURE 30: ILLUMINA HELD THE LEADING POSITION IN THE NEXT-GENERATION SEQUENCING MARKET AS OF 2018
  • FIGURE 31: ILLUMINA HELD THE LEADING POSITION IN THE NGS PLATFORMS MARKET AS OF 2018
  • FIGURE 32: ILLUMINA: COMPANY SNAPSHOT (2018)
  • FIGURE 33: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 34: PERKINELMER: COMPANY SNAPSHOT (2018)
  • FIGURE 35: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2018)
  • FIGURE 36: QIAGEN N.V. : COMPANY SNAPSHOT (2018)
  • FIGURE 37: F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2018)
  • FIGURE 38: BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 39: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 40: TAKARA BIO: COMPANY SNAPSHOT (2018)
  • FIGURE 41: TECAN: COMPANY SNAPSHOT (2018)
Back to Top